High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
Phase II Study of RR110 in Patients With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Abatacept in Patients With Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE3
Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes
- Status
- WITHDRAWN
- Phase
- NA
Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease.
- Status
- COMPLETED
- Phase
- NA
VSL#3 Treatment in Children With Crohn's Disease
- Status
- UNKNOWN
- Phase
- PHASE4
Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)
- Status
- TERMINATED
- Phase
- NA
A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
- Status
- WITHDRAWN
- Phase
- PHASE3
Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease
- Status
- UNKNOWN
- Phase
- PHASE1
Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE3
Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon
- Status
- COMPLETED
- Phase
- PHASE3
Dietary Treatment of Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)
- Status
- COMPLETED
- Phase
- PHASE3
Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sargramostim in Moderately to Severely Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)
- Status
- COMPLETED
- Phase
- PHASE2